Researchers from the National University of Singapore (NUS) have solved a 60-year-old mystery in bacterial cell envelope ...

Gram-negative bacterial infections are becoming an increasingly serious global health issue U.S. patent applications filed for three novel drug candidates: PKL200, TSL2200, and EAL2200 Continued ...

Gram-negative bacterial infections are becoming an increasingly serious global health issueU.S. patent applications filed for three novel drug candidates: PKL200, TSL2200, and EAL2200Continued ...

Gram-negative bacterial infections are the leading cause of death associated with antibiotic resistance, and no new class of drug has been developed against these pathogens in over 50 years. Now ...

When tested on their own and in mice, these bacterial strains from the human microbiome show promise in accumulating PFAS ...

Gram-negative bacteria deploy a range of protein toxins as mediators of inter-bacterial competition and pathogenicity. Among these, colicins comprise a class of ribosomally synthesised ...

Cambridge scientists have spotted gut bacteria that greedily soak up PFAS “forever chemicals,” then ferry them safely out of ...

Background In 2011, there were approximately two million cases of hospital-acquired infections in the United States, more than 75,000 of which were fatal. [1] Gram-negative bacteria cause the four ...

The rise of multidrug-resistant (MDR) Gram-negative bacteria necessitates novel therapeutic approaches. This study demonstrates the in vitro synergistic activity of ciprofloxacin (CIP), a ...

Extended therapy makes a difference Coliform mastitis can cause adverse impacts on dairy operations. Gram-negative bacteria, like E. coli, cause 40 percent of all clinical mastitis cases.2 Supported ...